You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 12, December 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Neurogenetics
 •Lewy Body Disease
 •Alert me on articles by topic

New Presenilin 1 Mutation With Alzheimer Disease and Lewy Bodies

Arch Neurol. 2005;62:1808.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The rare families with early-onset Alzheimer disease (AD) and autosomal dominant inheritance have been important in elucidating mutations in the presenilin 1 (PS1) and 2 genes and in the amyloid precursor protein gene that cause disease.1 These 3 gene mutations underscore the critical importance of normal amyloid precursor protein processing and the fact that a 50% increase in the amount of amyloid-{beta} peptide (A{beta}42) produced as a result of these mutations is sufficient to cause increased accumulation of A{beta}42, which in part causes the early and severe dementia. Abnormal amyloidogenesis is the predominant hypothesis to explain increased A{beta}42 burden in the brain of patients with AD and the resultant dementia.1 Another major unresolved issue in understanding the genetic and molecular basis of AD is the role of Lewy bodies, composed mainly of {alpha}-synuclein. Brains affected by AD may contain significant levels of Lewy bodies diffusely in neocortical and . . . [Full Text of this Article]

AUTHOR INFORMATION

Roger N. Rosenberg, MD, Editor


RELATED ARTICLE

Novel Presenilin 1 Mutation (S170F) Causing Alzheimer Disease With Lewy Bodies in the Third Decade of Life
B. Joy Snider, Joanne Norton, Mary A. Coats, Sumi Chakraverty, Craig E. Hou, Ramiro Jervis, Corinne L. Lendon, Alison M. Goate, Daniel W. McKeel, Jr, and John C. Morris
Arch Neurol. 2005;62(12):1821-1830.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Enhanced Accumulation of Phosphorylated {alpha}-Synuclein and Elevated -Amyloid 42/40 Ratio Caused by Expression of the Presenilin-1 {Delta}T440 Mutant Associated with Familial Lewy Body Disease and Variant Alzheimer's Disease
Kaneko et al.
J. Neurosci. 2007;27:13092-13097.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.